lapatinib has been researched along with Cancer, Second Primary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortes, J; Dang, C; Gilsenan, A; Hackshaw, MD; Layton, JB; Lee, C; Perez, EA; Singh, J; Wang, K | 1 |
| Chi, Y; Du, Y; Li, H; Man, X; Shan, C; Shang, M; Tan, Q; Wang, J; Yi, W; Yin, S | 1 |
| Bao, Y; Cai, L; He, X; Li, X; Wang, X; Zhang, Z | 1 |
| Kumar, PV; Prabaharan, S; Ravind, R | 1 |
| Keane, MP; Kelly, E; McDonnell, TJ; Mhurchu, EN; Sukor, S; Tryfonopoulos, D | 1 |
1 review(s) available for lapatinib and Cancer, Second Primary
| Article | Year |
|---|---|
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Female; Humans; Incidence; Lapatinib; Maytansine; Neoplasms, Second Primary; Receptor, ErbB-2; Trastuzumab | 2022 |
4 other study(ies) available for lapatinib and Cancer, Second Primary
| Article | Year |
|---|---|
Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Lapatinib; Neoplasms, Second Primary; Receptor, ErbB-2; Trastuzumab | 2023 |
Cost-Effectiveness of Pyrotinib Plus Capecitabine versus Lapatinib Plus Capecitabine for the Treatment of HER2-Positive Metastatic Breast Cancer in China: A Scenario Analysis of Health Insurance Coverage.
Topics: Acrylamides; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Insurance Coverage; Lapatinib; Neoplasms, Second Primary; Trastuzumab | 2022 |
Inflammatory breast cancer in a previously treated case of breast cancer: a diagnostic dilemma for the clinician.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Humans; Inflammatory Breast Neoplasms; Lapatinib; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Prognosis; Quinazolines | 2016 |
Chemotherapy-associated recurrent pneumothoraces in lymphangioleiomyomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Lapatinib; Lung Neoplasms; Lymphangioleiomyomatosis; Middle Aged; Neoplasms, Second Primary; Oxygen Inhalation Therapy; Pneumothorax; Quinazolines; Trastuzumab | 2010 |